These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 223053)

  • 1. Drug therapy: Disorders of neuromuscular transmission caused by drugs.
    Argov Z; Mastaglia FL
    N Engl J Med; 1979 Aug; 301(8):409-13. PubMed ID: 223053
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug effects on neuromuscular transmission.
    Howard JF
    Semin Neurol; 1990 Mar; 10(1):89-102. PubMed ID: 2161128
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)].
    Blanloeil Y; Baron D; Gazeau MF; Nicolas F
    Anesth Analg (Paris); 1980; 37(7-8):441-3. PubMed ID: 7425327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)].
    Jurenić D; Jusić A
    Neurologija; 1978; 26(1-4):37-9. PubMed ID: 754038
    [No Abstract]   [Full Text] [Related]  

  • 5. Penicillamine-induced myasthenic responses in the guinea pig.
    Burres SA; Richman DP; Crayton JW; Arnason BG
    Muscle Nerve; 1979; 2(3):186-90. PubMed ID: 228188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs and myasthenia gravis. An update.
    Wittbrodt ET
    Arch Intern Med; 1997 Feb; 157(4):399-408. PubMed ID: 9046891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D-penicillamine on neuromuscular transmission in rats.
    Aldrich MS; Kim YI; Sanders DB
    Muscle Nerve; 1979; 2(3):180-5. PubMed ID: 228187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs that may exacerbate myasthenia gravis.
    Adams SL; Mathews J; Grammer LC
    Ann Emerg Med; 1984 Jul; 13(7):532-8. PubMed ID: 6742556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced myasthenic syndromes.
    Kaeser HE
    Acta Neurol Scand Suppl; 1984; 100():39-47. PubMed ID: 6148832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuromuscular blocking effects of therapeutic concentrations of various antibiotics on normal rat skeletal muscle: a quantitative comparison.
    Caputy AJ; Kim YI; Sanders DB
    J Pharmacol Exp Ther; 1981 May; 217(2):369-78. PubMed ID: 6112258
    [No Abstract]   [Full Text] [Related]  

  • 12. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)].
    Cadisch R; Streit E; Hartmann K
    Schweiz Med Wochenschr; 1996 Feb; 126(8):308-10. PubMed ID: 8701248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 14. Hazard from antibiotics in myasthenia gravis.
    McQuillen MP
    Ann Intern Med; 1970 Sep; 73(3):487-8. PubMed ID: 4318447
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphology of the motor endplate. Aspects of interest in neurology].
    Sannomiya P; Manreza LA; Zanini AC
    Arq Neuropsiquiatr; 1975 Sep; 33(3):252-60. PubMed ID: 170897
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-induced neurologic disorders. Peripheral neuropathies. Ototoxicity. Disorders of neuromuscular transmission].
    Manigand G
    Therapie; 1982; 37(3):225-48. PubMed ID: 6291190
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effect of verapamil in myasthenia gravis.
    Swash M; Ingram DA
    Muscle Nerve; 1992 Mar; 15(3):396-8. PubMed ID: 1557089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggravation of myasthenia gravis by erythromycin.
    Absher JR; Bale JF
    J Pediatr; 1991 Jul; 119(1 Pt 1):155-6. PubMed ID: 1648610
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and pharmacological examination of neuromuscular transmission].
    Defféminis Rospide HA; Scarabino R; Silva Gaudin E
    Acta Neurol Latinoam; 1969; 15(1):117-26. PubMed ID: 4329847
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of delta 9-tetrahydrocannabinol on excitable membranes and neuromuscular transmission.
    Kumbaraci NM; Nastuk WL
    Mol Pharmacol; 1980 May; 17(3):344-9. PubMed ID: 6248762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.